No Blockbuster in the Obesity Drug Market, but Fluctuation in Next Year?

Published: 2014-09-12 15:29:34

Updated: 2014-09-12 15:29:34

The obesity drug market which was reorganized with a psychotropic appetite suppressant has not produced blockbuster for a long time.

It is understood because of strong regulatory policies regarding psychotropic appetite suppressant and lower performance of the highlighted drugs such as Roche Xenical.

A leading product, Dream Pharma Furing Tab recorded 4.3 billion won for the first half of thi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.